Synthesis and In vitro Evaluation of Thiadiazole Derivatives as AChE, BuChE and LOX Inhibitors


ALTINTOP M. D., ÖZDEMİR A., Abu Mohsen U., TEMEL H. E., AKALIN ÇİFTÇİ G., KAPLANCIKLI Z. A.

LETTERS IN DRUG DESIGN & DISCOVERY, vol.11, no.9, pp.1062-1069, 2014 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 9
  • Publication Date: 2014
  • Doi Number: 10.2174/1570180811666140529004517
  • Journal Name: LETTERS IN DRUG DESIGN & DISCOVERY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1062-1069
  • Keywords: Acetylcholinesterase, butyrylcholinesterase, lipoxygenase, thiadiazole, ALZHEIMERS-DISEASE, CHOLINESTERASE-INHIBITORS, BIOLOGICAL-ACTIVITIES, 1,3,4-THIADIAZOLE
  • Bilecik Şeyh Edebali University Affiliated: No

Abstract

N'-Benzylidene-2-[[5-(phenylamino)-1,3,4-thiadiazol-2-yl]thio]acetohydrazide derivatives (5a-p) were synthesized to screen for their AChE, BuChE and LOX inhibitory activity. The CCK-8 assay was also carried out to determine their cytotoxicity against NIH/3T3 cells. The most potent AChE inhibitors were found as compounds 5m (49.79% +/- 3.08) and 5p (42.39% +/- 3.19), whereas the most potent BuChE inhibitor was found as compound 5d (35.15% +/- 2.21). Among these derivatives, N'-(3-methoxybenzylidene)-2-[[5-(phenylamino)-1,3,4-thiadiazol-2-yl]thio]acetohydrazide (5p) can be considered as the most promising AChE inhibitor due to its low cytotoxicity to NIH/3T3 cells (IC50 > 500 mu g/mL). N'-(4-Methoxybenzylidene)- 2-[[5-(phenylamino)-1,3,4-thiadiazol-2-yl]thio]a-cetohydrazide (5n) exhibited weak inhibition on LOX (% 20.65 +/- 0.08), whilst the other compounds were not active.